Shigeto Kubo

BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

D Li, Lauren Ambrogio, Takeshi Shimamura et al. · Oncogene · 2008 · 1.4K citations · Full text

Medicine, Oncology, Pharmacology +11

Bronchial and Peripheral Murine Lung Carcinomas Induced by T790M-L858R Mutant EGFR Respond to HKI-272 and Rapamycin Combination Therapy

Danan Li, Takeshi Shimamura, Hongbin Ji et al. · Cancer Cell · 2007 · 235 citations · Full text

Medicine, Cancer Biology, Oncology +11

Cardiac Functional Analysis with Multi–Detector Row CT and Segmental Reconstruction Algorithm: Comparison with Echocardiography, SPECT, and MR Imaging

Masaki Yamamuro, Eiji Tadamura, Shigeto Kubo et al. · Radiology · 2005 · 235 citations

Medicine, Cardiology, Radiology +17

HER2 ^YVMA drives rapid development of adenosquamous lung tumors in mice that are sensitive to BIBW2992 and rapamycin combination therapy

Samanthi A. Perera, Danan Li, Takeshi Shimamura et al. · Proceedings of the National Academy of Sciences · 2009 · 179 citations · Full text

Medicine, Cancer Biology, Pharmacology +17

Effectiveness of Delayed Enhanced MRI for Identification of Cardiac Sarcoidosis: Comparison with Radionuclide Imaging

Eiji Tadamura, Masaki Yamamuro, Shigeto Kubo et al. · American Journal of Roentgenology · 2005 · 165 citations

Medicine, Cardiology, Radiology +15